2024年至2032年醫療冷鏈儲存設備市場機會、成長動力、產業趨勢分析與預測

2023年，全球醫療冷鏈儲存設備市場價值為29億美元，預計2024年至2032年複合年成長率為5.3%。冷鏈儲存在確保疫苗和生物製劑等溫度敏感醫療產品的安全運輸和儲存方面發揮著至關重要的作用。技術進步正在重塑冷鏈倉儲產業。物聯網 (IoT) 技術的整合可以即時監控溫度和濕度水平，確保產品在整個供應鏈中保持最佳狀態。

此外，區塊鏈技術正在探索增強可追溯性和透明度，有助於防止假冒產品並確保藥品的真實性。然而，先進技術和基礎設施的高昂初始成本構成了挑戰，特別是對於小型公司和發展中市場而言。如果管理不當，與溫度控制、運輸和法規遵循相關的複雜物流可能會導致效率低下。此外，冷儲存對穩定電源的依賴使其容易受到電網故障或自然災害的干擾，從而損害產品的完整性。

在設備方面，冷凍櫃領域2023年產值約為11億美元，預計2024年至2032年複合年成長率為5.9%。環保冷媒，降低營運成本和環境影響。 2023 年，製藥業約佔33% 的市場佔有率，預計到2032 年將以5.6% 的複合年成長率成長。鏈解決方案。對生物製劑和疫苗儲存和運輸的監管要求促使製藥公司採用尖端設備，包括支援物聯網的監控系統，該系統可提供即時資料，以最大限度地減少變質風險。北美在2023 年以32% 的佔有率引領市場，預計到2032 年將以5.4% 的複合年成長率成長。工作推動的。

FDA 和 CDC 等機構的嚴格法規要求藥品具有精確的儲存條件，促使醫院和製造商投資於合規設備。此外，物聯網和智慧監控系統的進步透過即時追蹤和溫度偏差自動警報提高了冷鏈儲存的可靠性和效率

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：產業洞察

• 產業生態系統分析
  • 影響價值鏈的因素。
  • 利潤率分析。
  • 干擾
  • 未來展望
  • 製造商
  • 經銷商
• 產業影響力
  • 成長動力
    • 對疫苗和生物製劑的需求不斷增加
    • 生物製藥產業的成長
  • 產業陷阱與挑戰
    • 初期投資高
    • 供應鏈中斷
• 成長潛力分析
• 未來趨勢分析
• 價格分析
• 技術景觀
• 監理框架
• 波特的分析
• PESTEL分析

第 4 章：競爭格局

• 公司市佔率分析
• 競爭定位矩陣
• 戰略展望矩陣

第 5 章：市場估計與預測：按設備類型

• 主要趨勢
• 冰箱
  • 實驗室冰箱
  • 血庫冰箱
  • 藥房冰箱
  • 色譜冰箱
• 冰櫃
  • 超低溫冷凍櫃
  • 等離子冷凍機
  • 冷凍櫃
• 低溫儲存系統
  • 液態氮儲存系統
  • 氣相儲存系統
• 涼室
• 其他（冰襯冰箱、太陽能直驅冰箱等）

第 6 章：市場估計與預測：依溫度範圍

• 主要趨勢
• 2°C 至 8°C
• -20°C 至 -40°C
• -40°C 至 -80°C
• -80度C以下

第 7 章：市場估計與預測：按產能

• 主要趨勢
• 小號（最多 300 公升）
• 中型（300-700公升）
• 大號（700公升以上）

第 8 章：市場估計與預測：依技術分類

• 主要趨勢
• 基於壓縮機的系統
• 基於吸收的系統
• 基於熱電的系統

第 9 章：市場估計與預測：按應用

• 主要趨勢
• 疫苗儲存
• 血液及血液製品儲存
• 生物樣本儲存
• 藥品及藥品儲存
• 其他（器官儲存、細胞培養基等）

第 10 章：市場估計與預測：依最終用途

• 主要趨勢
• 醫院和診所
• 製藥公司
• 研究實驗室
• 血庫
• 藥局
• 其他（學術機構、診斷中心等）

第 11 章：市場估計與預測：按地區

• 主要動向：按地區
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
• 拉丁美洲
  • 巴西
  • 墨西哥
• MEA
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第 12 章：公司簡介

• Azenta
• Binder
• Cardinal Health
• Carebios Biological Technology
• Darwin Chambers
• Elanpro
• Farrar
• Haier Biomedical
• Hoshizaki America
• Kendall Cold Chain System
• Memmert
• Philipp Kirsch
• Roemer Industries
• Summit Appliance
• Thalheimer Kuhlung

The Global Medical Cold Chain Storage Equipment Market was valued at USD 2.9 billion in 2023 and is projected to grow at 5.3% CAGR from 2024 to 2032. The rising demand for pharmaceuticals, fueled by medical advancements and an aging population, drives the market growth. Cold chain storage plays a critical role in ensuring the safe transport and storage of temperature-sensitive medical products, such as vaccines and biologics. Technological advancements are reshaping the cold chain storage industry. The integration of Internet of Things (IoT) technology allows for real-time monitoring of temperature and humidity levels, ensuring that products remain within optimal conditions throughout the supply chain.

Additionally, blockchain technology is being explored to enhance traceability and transparency, helping to prevent counterfeit products and ensuring the authenticity of pharmaceuticals. However, high initial costs for advanced technology and infrastructure pose challenges, particularly for smaller companies and developing markets. Complex logistics related to temperature control, transportation, and regulatory compliance can lead to inefficiencies if not properly managed. Moreover, cold storage's reliance on consistent power supplies makes it susceptible to disruptions from grid failures or natural disasters, which can compromise product integrity.

In terms of equipment, the freezer segment generated around USD 1.1 billion in 2023 and is expected to grow at a CAGR of 5.9% from 2024 to 2032. Demand for ultra-low temperature freezers has surged, particularly for vaccine storage, driving innovation in energy-efficient technologies and environmentally friendly refrigerants, reducing both operational costs and environmental impact. The pharmaceutical sector accounted for roughly 33% of the market share in 2023 and is anticipated to grow at a CAGR of 5.6% through 2032. With a growing number of temperature-sensitive drugs, manufacturers are increasingly investing in advanced cold chain solutions. Regulatory requirements for the storage and transport of biologics and vaccines have prompted pharmaceutical companies to adopt cutting-edge equipment, including IoT-enabled monitoring systems that provide real-time data to minimize spoilage risks. North America led the market with a 32% share in 2023 and is expected to grow at a CAGR of 5.4% through 2032. The regional growth is driven by increasing demand for injections and biologics, healthcare infrastructure development, and ongoing R&D efforts.

Strict regulations from authorities like the FDA and CDC require precise storage conditions for pharmaceuticals, pushing hospitals and manufacturers to invest in compliant equipment. Additionally, advancements in IoT and smart monitoring systems are enhancing the reliability and efficiency of cold chain storage through real-time tracking and automated alerts for temperature deviations

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model.
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
  • 3.1.1 Factor affecting the value chain.
  • 3.1.2 Profit margin analysis.
  • 3.1.3 Disruptions
  • 3.1.4 Future outlook
  • 3.1.5 Manufacturers
  • 3.1.6 Distributors
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing demand for vaccines and biologics
    • 3.2.1.2 Growth in biopharmaceutical industry
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High initial investment
    • 3.2.2.2 Supply chain Disruptions
• 3.3 Growth potential analysis
• 3.4 Future trend analysis
• 3.5 Price analysis
• 3.6 Technological landscape
• 3.7 Regulatory framework
• 3.8 Porter's analysis
• 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Company market share analysis
• 4.2 Competitive positioning matrix
• 4.3 Strategic outlook matrix

Chapter 5 Market Estimates & Forecast, By Equipment Type (USD Billion) (Thousand Units)

• 5.1 Key trends
• 5.2 Refrigerators
  • 5.2.1 Laboratory refrigerators
  • 5.2.2 Blood bank refrigerators
  • 5.2.3 Pharmacy refrigerators
  • 5.2.4 Chromatography refrigerators
• 5.3 Freezers
  • 5.3.1 Ultra-low temperature freezers
  • 5.3.2 Plasma freezers
  • 5.3.3 Shock freezers
• 5.4 Cryogenic storage systems
  • 5.4.1 Liquid nitrogen storage systems
  • 5.4.2 Vapor phase storage systems
• 5.5 Cold rooms
• 5.6 Others (ice lined refrigerators, solar direct drive refrigerators etc.)

Chapter 6 Market Estimates & Forecast, By Temperature Range (USD Billion) (Thousand Units)

• 6.1 Key trends
• 6.2 2°C to 8°C
• 6.3 -20°C to -40°C
• 6.4 -40°C to -80°C
• 6.5 Below -80°C

Chapter 7 Market Estimates & Forecast, By Capacity (USD Billion) (Thousand Units)

• 7.1 Key trends
• 7.2 Small (up to 300 liters)
• 7.3 Medium (300-700 liters)
• 7.4 Large (above 700 liters)

Chapter 8 Market Estimates & Forecast, By Technology (USD Billion) (Thousand Units)

• 8.1 Key trends
• 8.2 Compressor-based systems
• 8.3 Absorption-based systems
• 8.4 Thermoelectric-based systems

Chapter 9 Market Estimates & Forecast, By Application (USD Billion) (Thousand Units)

• 9.1 Key trends
• 9.2 Vaccine storage
• 9.3 Blood & blood products storage
• 9.4 Biological sample storage
• 9.5 Drug & pharmaceutical storage
• 9.6 Others (organ storage, cell culture media etc.)

Chapter 10 Market Estimates & Forecast, By End Use (USD Billion) (Thousand Units)

• 10.1 Key trends
• 10.2 Hospitals & clinics
• 10.3 Pharmaceutical companies
• 10.4 Research laboratories
• 10.5 Blood banks
• 10.6 Pharmacies
• 10.7 Others (academic institutions, diagnostic centers etc.)

Chapter 11 Market Estimates & Forecast, By Region (USD Billion) (Thousand Units)

• 11.1 Key trends, by region
• 11.2 North America
  • 11.2.1 U.S.
  • 11.2.2 Canada
• 11.3 Europe
  • 11.3.1 Germany
  • 11.3.2 UK
  • 11.3.3 France
  • 11.3.4 Italy
  • 11.3.5 Spain
• 11.4 Asia Pacific
  • 11.4.1 China
  • 11.4.2 India
  • 11.4.3 Japan
  • 11.4.4 Australia
  • 11.4.5 South Korea
• 11.5 Latin America
  • 11.5.1 Brazil
  • 11.5.2 Mexico
• 11.6 MEA
  • 11.6.1 Saudi Arabia
  • 11.6.2 UAE
  • 11.6.3 South Africa

Chapter 12 Company Profiles

• 12.1 Azenta
• 12.2 Binder
• 12.3 Cardinal Health
• 12.4 Carebios Biological Technology
• 12.5 Darwin Chambers
• 12.6 Elanpro
• 12.7 Farrar
• 12.8 Haier Biomedical
• 12.9 Hoshizaki America
• 12.10 Kendall Cold Chain System
• 12.11 Memmert
• 12.12 Philipp Kirsch
• 12.13 Roemer Industries
• 12.14 Summit Appliance
• 12.15 Thalheimer Kuhlung